Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
The inflammaging microenvironment induces dysfunctional rewiring of Tfh cell differentiation
Cody S. Nelson, Manuel A. Podestà, Maya G. Gempler, Jeong-Mi Lee, Cole J. Batty, Peterson G. Mathenge, Asra Sainju, Matthew R. Chang, Hanzhong Ke, Pragya Chandrakar, Elsa Bechu, Sierra Richardson, Cecilia B. Cavazzoni, Stefan G. Tullius, Reza Abdi, Musie Ghebremichael, Marcia C. Haigis, Wayne A. Marasco, Peter T. Sage
Cody S. Nelson, Manuel A. Podestà, Maya G. Gempler, Jeong-Mi Lee, Cole J. Batty, Peterson G. Mathenge, Asra Sainju, Matthew R. Chang, Hanzhong Ke, Pragya Chandrakar, Elsa Bechu, Sierra Richardson, Cecilia B. Cavazzoni, Stefan G. Tullius, Reza Abdi, Musie Ghebremichael, Marcia C. Haigis, Wayne A. Marasco, Peter T. Sage
View: Text | PDF
Research Article Aging Immunology

The inflammaging microenvironment induces dysfunctional rewiring of Tfh cell differentiation

  • Text
  • PDF
Abstract

Humoral immunity is orchestrated by follicular helper T (Tfh) cells, which promote cognate B cells to produce high-affinity, protective antibodies. In aged individuals, humoral immunity after vaccination is diminished despite the presence of Tfh cells, suggesting defects after initial Tfh cell formation. In this study, we utilized both murine and human systems to investigate how aging alters Tfh cell differentiation after influenza vaccination. We found that young Tfh cells underwent progressive differentiation after influenza vaccination, culminating in clonal expansion of effector-like cells in both draining lymph nodes and blood. In aging, early stages of Tfh cell development occurred normally. However, aging rewired the later stages of development in Tfh cells, resulting in a transcriptional program reflective of cellular senescence, sustained pro-inflammatory cytokine production, and metabolic reprogramming. We investigated the extent to which this rewiring of aged Tfh cells is due to the age-associated inflammatory (“inflammaging”) microenvironment and found that this setting was sufficient to both block the transition of Tfh cells to a post-effector resting state and skew Tfh cells toward the age-rewired state. Together, these data suggest that aging dampens humoral immunity by cytokine-mediated rewiring of late effector Tfh cell differentiation into an activated, yet less functional, cellular state.

Authors

Cody S. Nelson, Manuel A. Podestà, Maya G. Gempler, Jeong-Mi Lee, Cole J. Batty, Peterson G. Mathenge, Asra Sainju, Matthew R. Chang, Hanzhong Ke, Pragya Chandrakar, Elsa Bechu, Sierra Richardson, Cecilia B. Cavazzoni, Stefan G. Tullius, Reza Abdi, Musie Ghebremichael, Marcia C. Haigis, Wayne A. Marasco, Peter T. Sage

×

Figure 4

Defective neutralizing antibody and ICOShiCD38hi Tfh cells in older humans after influenza vaccination.

Options: View larger image (or click on image) Download as PowerPoint
Defective neutralizing antibody and ICOShiCD38hi Tfh cells in older huma...
(A) Experimental schematic. 18 young (18–38 yr) and 78 aged (> 65 yr) adults were administered a seasonal influenza vaccine. Peripheral blood was obtained on the day of vaccination (d0), as well as day 7 (d7), day 14 (d14), and day 30 (d30) after vaccination. (B) (Left) Influenza H1 protein Meso Scale Discovery (MSD) binding index for young and aged vaccine recipients, separated by time point. (Right) Influenza H1 protein hemagglutination inhibition (HAI) titers. (C) Gating strategy to identify cTfh (CD3+CD4+CD8–CD14–CD19–CD45RA–CXCR5+FoxP3–) and Tfr (CD3+CD4+CD8–CD14–CD19–CD45RA–CXCR5+FoxP3+) cells from blood. (D) Total number of CD4+ T cells (per 1 × 106 input PBMC), separated by time point. (E) Tfh frequency of total CD4+ T cells, separated by time point. (F) Tfr frequency of total CD4+ T cells (left) and Tfh/Tfr ratio (right), separated by time point. (G and H) ICOShiCD38hi (G) or CD226+Tigit+ (H) frequency of Tfh cells, separated by time point. (I) Tfh cell polarization including Tfh1 (left), Tfh2 (middle), and Tfh17 (right) identified by indicated chemokine receptor expression. (J) PD-1 mean fluorescence intensity on total Tfh cells, separated by time point. (K) Forest plot indicating longitudinal modeling of indicated parameters (#CD4+ T cells, %cTfh, %cTfr, %ICOS+PD-1+, %ICOShiPD-1hi, %cTfh1, %cTfh2, %cTfh17, %CD226+Tigit+, CXCR5 MFI, and PD-1 MFI). (L) Spearman’s rank correlation for indicated parameters of interest. Linear regression of %ICOShiCD38hi cells with PD-1 MFI, for all cells at d30 time point. Bold italic indicates statistical significance. (Right) PD-1 MFI on total or ICOShiCD38hi Tfh cells. All displayed data points represent mean, with error bars indicating SEM. *P < 0.05, uncorrected Mann-Whitney U test.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts